betulinic acid and Alloxan Diabetes

betulinic acid has been researched along with Alloxan Diabetes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chao, X; Chen, C; Huang, H; Huang, J; Wang, S; Xiong, F; Yang, Z1
Ahn, YM; Choi, ES; Han, BH; Kang, DG; Kho, MC; Kim, HY; Lee, HS; Lee, YJ; Park, JH; Yoon, JJ1

Other Studies

2 other study(ies) available for betulinic acid and Alloxan Diabetes

ArticleYear
Betulinic acid ameliorates experimental diabetic-induced renal inflammation and fibrosis via inhibiting the activation of NF-κB signaling pathway.
    Molecular and cellular endocrinology, 2016, 10-15, Volume: 434

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; beta-Arrestin 2; Betulinic Acid; Cells, Cultured; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glucose; I-kappa B Proteins; Kidney; Mesangial Cells; NF-kappa B; Pentacyclic Triterpenes; Rats; Signal Transduction; Streptozocin; Triterpenes

2016
Protective effect of betulinic acid on early atherosclerosis in diabetic apolipoprotein-E gene knockout mice.
    European journal of pharmacology, 2017, Feb-05, Volume: 796

    Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Betulinic Acid; Blood Glucose; Diabetes Mellitus, Experimental; Gene Knockout Techniques; Hyperlipidemias; Hypertension; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Pentacyclic Triterpenes; Triterpenes

2017